Brief: Somnomed Reaffirms FY22 Forecast
27/04/2022 02:10
April 27 (Reuters) - Somnomed Ltd SOM.AX :
* FY22 GUIDANCE REAFFIRMED
* REVENUE OF A$17.3 MILLION FOR Q3 FY22, UP 10% PCP
* REMAINS OPTIMISTIC ABOUT TRADING ACTIVITY LEVELS AND
OUTLOOK FOR
FY22
Source text for Eikon: ID:nASX9CJdJp
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million